Akso Health Group- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Akso Health Group 公司

Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others. The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests.

Akso Health Group簡介



公司代碼AHG

公司名稱Akso Health Group

上市日期Nov 03, 2017

CEOAn (Xiaobo)

員工數量27

證券類型Depository Receipt

年結日Nov 03

公司地址Rm 8201-4-4(A) 2Nd Floor Qiantongyua Bld, No. 44 Moscow Rd Qianwan Bonded Port Are, Qingdao Pilot Free Trade Zone

城市QINGDAO

上市交易所NASDAQ OMX - NASDAQ BASIC

國家China

郵編- -

電話

網址https://www.ahgtop.com/en/index.html

公司代碼AHG

上市日期Nov 03, 2017

CEOAn (Xiaobo)

Akso Health Group公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Xiaobo An

Chairman of the Board, Chief Executive Officer

--

Ms. Rui (Kerrie) Zhang

Chief Financial Officer

--

Ms. Wenjuan (Vivian) Liu

Director

--

Mr. Stephen (Steven) Markscheid

Independent Director

--

Mr. Dagang Guo

Independent Director

--

Mr. David Wei Tang

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Xiaobo An

Chairman of the Board, Chief Executive Officer

--

Ms. Rui (Kerrie) Zhang

Chief Financial Officer

--

Ms. Wenjuan (Vivian) Liu

Director

--

Mr. Stephen (Steven) Markscheid

Independent Director

--

Mr. Dagang Guo

Independent Director

--

Mr. David Wei Tang

Independent Director

--

收入明細

單位: USD更新時間: 1月6日週二

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Marketing promotion service revenue

14.37M

97.22%

Sale of medical devices

415.02K

2.81%

Tax and surcharges

-3.82K

-0.03%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

Marketing promotion service revenue

14.37M

97.22%

Sale of medical devices

415.02K

2.81%

Tax and surcharges

-3.82K

-0.03%

股東統計

更新時間: 2月23日週日

持股股東

股東類型

持股股東

佔比

Renaissance Technologies LLC

0.02%

其他

99.98%

持股股東

佔比

Renaissance Technologies LLC

0.02%

其他

99.98%

股東類型

持股股東

佔比

Hedge Fund

0.02%

其他

99.98%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

10

144.21K

0.03%

-97.30K

2025Q3

12

157.24K

0.05%

-16.31K

2025Q2

14

173.55K

0.05%

-35.73K

2025Q1

14

209.28K

0.05%

-77.89K

2024Q4

14

234.20K

0.10%

+32.28K

2024Q3

15

201.92K

0.15%

-43.98K

2024Q2

15

245.90K

0.25%

-29.38K

2024Q1

15

275.29K

0.24%

-76.12K

2023Q4

17

276.30K

1.00%

-51.82K

2023Q3

17

328.12K

1.87%

-33.76K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Renaissance Technologies LLC

129.20K

0.02%

-1.60K

-1.22%

Sep 30, 2025

Geode Capital Management, L.L.C.

14.97K

0%

--

Sep 30, 2025

Catalina Capital Group, LLC

--

0%

-31.94K

-100.00%

Mar 31, 2025

Millennium Management LLC

--

0%

-22.83K

-100.00%

Jun 30, 2025

Rhumbline Advisers Ltd. Partnership

--

0%

-4.54K

-100.00%

Sep 30, 2025

Geowealth Management LLC

--

0%

-1.33K

-100.00%

Jun 30, 2025

UBS Financial Services, Inc.

13.03K

0%

+70.00

+0.54%

Sep 30, 2025

Aperio Group, LLC

37.00

0%

+37.00

--

Sep 30, 2025

Two Sigma Investments, LP

--

0%

-10.28K

-100.00%

Sep 30, 2025

XTX Markets LLC

--

0%

-11.79K

-100.00%

Jun 30, 2024

持股ETF



機構名稱

佔比

暫無數據

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

除權除息日

類型

比率

Aug 10, 2020

Merger

3→1

Aug 10, 2020

Merger

3→1

Aug 10, 2020

Merger

3→1

Aug 10, 2020

Merger

3→1

公告日期

除權除息日

類型

比率

Aug 10, 2020

Merger

3→1

Aug 10, 2020

Merger

3→1

Aug 10, 2020

Merger

3→1

Aug 10, 2020

Merger

3→1